Oct. 4 at 8:46 PM
$ESPR ESPR was able to work some magic getting several generics previously and just yesterday landing the biggest , Dr. Reddys, this should quickly get the few remaining holdouts to agree as well. Sheldon has always said that he felt they would be able to protect BA’s US rights until 2040 and now it’s coming to fruition. The dollar value this adds to the stock is mammoth, perhaps this was the final piece to land one the many big pharmas eyeing little old Esperion with its tiny 150 US sales .
Some may no be able to see opportunity but rest assured that BP won’t miss this chance and IMO they won’t sit back and wait until this market cap (which is undervalued) gets back to some reality, no no, they will attempt to scoop it up relatively cheap. This is a great time for the suffering longs and a tremendous opportunity for anyone just stumbling across this. Do some research, this thing was
$100 at one time and about
$70 at FDA approved. (Past dilution I realize but still undervalued ) 📈🎯
